LGM Pharma Blog Charting New Territory: Pharma’s API Sourcing Challenges

The global shift in active pharmaceutical ingredient (API) sourcing from China to India is redefining the supply chain, offering new opportunities while introducing additional challenges for drug manufacturers worldwide. As India emerges as a key player in API production, pharmaceutical companies must adapt to the complexities for sourcing in this evolving market. API sourcing has […]